p53 status and human papillomavirus infection in Thai women with cervical carcinoma.
Loss of p53 function has been implicated in a wide variety of human malignacies. Many studies suggest that in cervical carcinoma p53 function is inactivated either by gene mutation or by complex formation with E6 oncoprotein product of high-risk human papillomavirus (HPV). The aim of this study was to determine the status of HPV infection and p53 gene mutation as well as their correlation in cervical carcinomas. Formalin-fixed paraffin-embedded tissues of 12 cervicitis, 21 cervical intraepithelial neoplasia grade 3 (CIN 3) and 17 squamous cell carcinomas were determined for the presence of HPV using polymerase chain reaction (PCR) amplification and dot blot hybridization. The status of p53 mutations in exons 5-8 was evaluated by polymerase chain reaction single strand conformation polymorphism (PCR-SSCP) and confirmed by direct nucleotide sequencing. HPV infections were detected in all CIN 3 and squamous cell carcinomas (100%). Mutations of p53 were present in 3 of 38 HPV-positive samples: one with an ATG-->TTG transversion (Met-->Leu) in codon 237 of exon 7; and the others with a TGC-->TGG transversion (Cys-->Trp) in codon 242 of exon 7, and a CGT-->CCT transversion (Arg-->Pro) in codon 273 of exon 8, respectively. Our findings show that the frequency of p53 mutation is low in primary cervical carcinoma and that the p53 gene mutation and HPV infection are not mutually exclusive events in the development of cervical cancer. Thus, other genetic events independent of p53 inactivation may also significantly contribute to the carcinogenesis of the uterine cervix.
Limpaiboon
T
T
Department of Clinical Chemistry, Faculty of Associated Medical Sciences, Khon Kaen University, Thailand. temduang@kku1.kku.ac.th
Pooart
J
J
Bhattarakosol
P
P
Niruthisard
S
S
Chantratita
W
W
Lulitanond
V
V
D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000235:genetics / Q000821:virology; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D016158:Genes, p53; D006801:Humans; D009154:Mutation; D009693:Nucleic Acid Hybridization; D027383:Papillomaviridae / Q000145:classification / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000150:complications* / Q000821:virology; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D013785:Thailand; D014412:Tumor Virus Infections / Q000150:complications* / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000150:complications / Q000235:genetics* / Q000821:virology*; D002575:Uterine Cervicitis / Q000150:complications / Q000235:genetics / Q000821:virology; D002578:Uterine Cervical Dysplasia / Q000150:complications / Q000235:genetics / Q000821:virology
D004279:DNA, Viral